X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

GCC In-Vitro Diagnostics Companies

This report lists the top GCC In-Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the GCC In-Vitro Diagnostics industry.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research In Vitro Diagnostic Devices Research GCC In Vitro Diagnostics Industry Companies

GCC In-Vitro Diagnostics Top Companies

  1. Abbott Laboratories.

  2. Danaher Corporation

  3. F. Hoffmann-La Roche AG

  4. Becton, Dickinson and Company

  5. Sysmex Corporation

*Disclaimer: Top companies sorted in no particular order

GCC In-Vitro Diagnostics Market Major Players

GCC In-Vitro Diagnostics Market Concentration

GCC In-Vitro Diagnostics Market Concentration

GCC In-Vitro Diagnostics Company List

                          • Abbott Laboratories

                          • Danaher Corporation

                          • F. Hoffmann-La Roche AG

                          • Becton, Dickinson and Company

                          • BioMerieux SA

                          • Siemens Healthineers (Siemens Healthcare GmbH)

                          • Thermo Fischer Scientific Inc.

                          • Qiagen NV

                          • Sysmex Corporation

                          • Grifols SA

                          • DiaSorin

                          • Bio-Rad Laboratories


                      Specific to GCC In-Vitro Diagnostics Market
                      Need More Details On Market Players And Competitors?
                      Download Sample

                      GCC In Vitro Diagnostics Market Report Snapshots

                      GCC In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)